These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6530379)

  • 41. Chemical composition, serological reactivity and endotoxicity of lipopolysaccharides extracted in different ways from Bacteroides fragilis, Bacteroides melaninogenicus and Bacteroides oralis.
    Hofstad T; Sveen K; Dahlén G
    Acta Pathol Microbiol Scand B; 1977 Aug; 85(4):262-70. PubMed ID: 19922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The humoral antibody response to Bacteroides fragilis infections in humans.
    Lindberg AA; Weintraub A; Nord CE
    Scand J Infect Dis Suppl; 1979; (19):46-51. PubMed ID: 288165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
    J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of the surface and somatic antigens of Bacteroides fragilis.
    Elhag KM; Tabaqchali S
    J Hyg (Lond); 1978 Jun; 80(3):439-49. PubMed ID: 649950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluorescent-antibody studies on selected strains of Bacteroides fragilis subspecies fragilis.
    Abshire RL; Lombard GL; Dowell VR
    J Clin Microbiol; 1977 Oct; 6(4):425-32. PubMed ID: 72076
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of Bacteroides fragilis group by immunofluorescence.
    Radu I; Bittner J; Macovei A; Costache L; Mihalache D; Munteanu V
    Roum Arch Microbiol Immunol; 1991; 50(2):95-108. PubMed ID: 1820192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of cell-surface antigens of Bacteroides thetaiotaomicron in the passive hemagglutination test and in the inhibition of passive hemagglutination].
    Rokosz A; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1995; 47(3-4):189-95. PubMed ID: 8833931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.
    Kasper DL; Onderdonk AB; Reinap BG; Linberg AA
    J Infect Dis; 1980 Nov; 142(5):750-6. PubMed ID: 7462689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The cell-surface components of Bacteroides thetaiotaomicron as coating antigens in ELISA test.
    Rokosz A; Grzybowski J; Kaca W; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1989; 38(3-4):285-91. PubMed ID: 2484745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.
    Reid JH; Patrick S; Tabaqchali S
    J Gen Microbiol; 1987 Jan; 133(1):171-9. PubMed ID: 3309142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precipitating antigens of Bacteroides fragilis NCTC 2553.
    Mathai E; Lalitha MK
    Indian J Med Res; 1985 Dec; 82():559-61. PubMed ID: 3833709
    [No Abstract]   [Full Text] [Related]  

  • 52. The influence of specific antibodies and cellular immunity in the induction of tolerance of chemotactic activity caused by Bacteroides fragilis lipopolysaccharide.
    Sveen K; Hofstad T
    Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):341-5. PubMed ID: 117673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunochemical evidence for multiple serotypes of Bacteroides fragilis.
    Cherniak R; Lombard GL; Dowell VR
    J Clin Microbiol; 1979 Jun; 9(6):699-704. PubMed ID: 91622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Capsular and 'O' serotype determinants of bacteroides fragilis.
    Tabaqchali S; Fiddian PA; El-Hag K; Kasper DL
    Infection; 1982; 10(6):333-7. PubMed ID: 6185437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.
    Mancuso G; Midiri A; Biondo C; Beninati C; Gambuzza M; Macrì D; Bellantoni A; Weintraub A; Espevik T; Teti G
    Infect Immun; 2005 Sep; 73(9):5620-7. PubMed ID: 16113279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of a specific bacterial antigen in urine of rats with Bacteroides fragilis infection.
    Rissing JP; Buxton TB; Harris RW; Shockley RK; Craven P; Moore WL
    J Lab Clin Med; 1983 Sep; 102(3):392-9. PubMed ID: 6886522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of lipopolysaccharide and outer membrane of Bacteroides fragilis by an antibody-inhibition enzyme-linked immunosorbent assay in physiologic fluids and infected animals.
    Rissing JP; Buxton TB; Harris R; Moore W
    J Lab Clin Med; 1981 Nov; 98(5):784-94. PubMed ID: 7299246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fimbriae and hemagglutination in the Bacteroides fragilis group.
    Shinjo T; Kiyoyama H
    Nihon Juigaku Zasshi; 1984 Jun; 46(3):373-5. PubMed ID: 6148443
    [No Abstract]   [Full Text] [Related]  

  • 59. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody response in thirteen patients with Bacteroides fragilis infections.
    Schwan A; Rydén AC
    Scand J Infect Dis; 1978; 10(3):213-8. PubMed ID: 362516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.